Positive association of CD36 gene variants with the visual outcome of photodynamic therapy in polypoidal choroidal vasculopathy
Authors:
- Shigeru HondaSHShigeru Honda
- Hiroaki BesshoHBHiroaki Bessho
- Naoshi KondoNKNaoshi Kondo
- Sentaro KusuharaSKSentaro Kusuhara
- Yasutomo TsukaharaYTYasutomo Tsukahara
- Akira NegiANAkira Negi
Open Access
- 22 November 2012
- journal article
- Vol. 18, 2796-2804
Abstract
To clarify the association between cluster of differentiation 36 (CD36) gene polymorphisms and the response to photodynamic therapy (PDT) in polypoidal choroidal vasculopathy (PCV). One hundred and thirty-seven patients with PCV were enrolled. The patients were treated with PDT and followed up for more than 6 months. Retreatments were performed every 3 months as needed based on findings from angiography. Patients who showed an improvement in their best-corrected visual acuity at 6 months post-PDT were classified as PDT responders, and the others were defined as non-responders. For the 73 responders and 64 non-responders, 19 single nucleotide polymorphisms (SNPs) across the CD36 region were genotyped using the TaqMan assay. We analyzed the association between these variants and the visual outcomes of PDT. The allelic frequencies of the SNPs rs3211851, rs3173798, and rs3211908 showed nominally significant differences between the PDT responders and non-responders. Genotype association analysis revealed a significant association of SNP rs3173798 with the visual outcome of PDT in a dominant model. The presence of the C allele in rs3173798 was significantly associated with a poor response to PDT after multivariate logistic regression analysis with clinical pre-PDT parameters. The mean best-corrected visual acuity in the group with the TT genotype of rs3173798 was significantly improved over 12 months of follow-up after the initial PDT. The coding variants in CD36 are possibly associated with the visual outcome of PDT in patients with PCV.Keywords
This publication has 40 references indexed in Scilit:
- Association between the SERPING1 Gene and Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in JapanesePLOS ONE, 2011
- Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profileHuman Molecular Genetics, 2010
- CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and BehaviorScience Signaling, 2009
- Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterolHuman Molecular Genetics, 2008
- CD36 Deficiency Leads to Choroidal Involution via COX2 Down-Regulation in RodentsPLOS Medicine, 2008
- FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritizationNucleic Acids Research, 2006
- Efficiency and power in genetic association studiesNature Genetics, 2005
- The International HapMap ProjectNature, 2003
- CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolismJournal of Clinical Investigation, 2001
- VerteporfinDrugs & Aging, 2000